Home › Funds › Saturn V Capital Management LP › JAZZ
Saturn V Capital Management LP position in JAZZ
JAZZ PHARMACEUTICALS PLC SHS USD · Health Care
Saturn V Capital Management LP reported holding 160,938 shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) in its Q2 2026 13F filing — a position valued at US$38.8M, representing 5.56% of its reported portfolio and ranking #7 among its reported holdings. Saturn V Capital Management LP has disclosed JAZZ holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Saturn V Capital Management LP's JAZZ position evolved
Saturn V Capital Management LP first disclosed a stake in JAZZ in Q2 2025 at 206,952 shares (US$22.0M). The position peaked in Q4 2025 at 248,070 shares, worth US$42.2M. Across 5 filings, Saturn V Capital Management LP increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 160,938 shares valued at US$38.8M — a reduction of -2,023 shares quarter over quarter.. Notable position changes include a 45% increase in Q3 2025 (shares rose 29% over the following quarter), a 34% trim in Q1 2026 (shares rose 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 206.95K | $21.96M | New |
| Q3 2025 | 300.61K | $39.62M | Add |
| Q4 2025 | 248.07K | $42.17M | Reduce |
| Q1 2026 | 162.96K | $30.81M | Reduce |
| Q2 2026 | 160.94K | $38.78M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JAZZ and 13F data
JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) is a Health Care company. 44 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$394.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), GMT CAPITAL CORP (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JAZZ
- FULLER & THALER ASSET MANAGEMENT, INC. 1.64M sh · $394.84M · Q2 2026
- MILLENNIUM MANAGEMENT LLC 763.88K sh · $184.07M · Q2 2026
- GMT CAPITAL CORP 453.50K sh · $109.28M · Q2 2026
- Boston Trust Walden Corp 443.12K sh · $106.78M · Q2 2026
- SYSTEMATIC FINANCIAL MANAGEMENT LP 378.71K sh · $91.26M · Q2 2026
- Sofinnova Investments, Inc. 365.34K sh · $88.04M · Q2 2026
More on Saturn V Capital Management LP
FAQ
How long has Saturn V Capital Management LP held JAZZ?
Saturn V Capital Management LP has disclosed JAZZ holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Saturn V Capital Management LP's current position in JAZZ?
As of Q2 2026, Saturn V Capital Management LP holds 160.94K shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD), valued at $38.78M, representing 5.56% of its reported portfolio and ranking #7.
Has Saturn V Capital Management LP been buying or selling JAZZ?
In the latest 13F filing (Q2 2026), Saturn V Capital Management LP reduced its position in JAZZ. The position peaked in Q4 2025 at 248.07K shares.
Which other funds hold JAZZ?
Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, GMT CAPITAL CORP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.